Variant report
Variant | nsv965564 |
---|---|
Chromosome Location | chr5:104314451-104329410 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NUDT12-7 | chr5:104315392-104315477 | ENSG00000253584 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528738165 | chr5:104315403-104315404 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs551494546 | chr5:104315404-104315405 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs564978992 | chr5:104315405-104315406 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs530791163 | chr5:104315414-104315415 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs73210379 | chr5:104315422-104315423 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs529541600 | chr5:104315435-104315436 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs80108303 | chr5:104321210-104321211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373961415 | chr5:104321233-104321234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571374077 | chr5:104321243-104321244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs75890009 | chr5:104321245-104321246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186352314 | chr5:104321259-104321260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544601978 | chr5:104321278-104321279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549520087 | chr5:104321309-104321310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569739609 | chr5:104321334-104321335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556942936 | chr5:104321336-104321337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535787563 | chr5:104321400-104321401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs3993310 | chr5:104322016-104322017 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs138139649 | chr5:104322032-104322033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560522900 | chr5:104322068-104322069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538989569 | chr5:104322076-104322077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558999490 | chr5:104322096-104322097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368884191 | chr5:104322100-104322101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557163977 | chr5:104322117-104322118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371559648 | chr5:104322175-104322176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373298039 | chr5:104322241-104322242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77272076 | chr5:104322249-104322250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556761595 | chr5:104322263-104322264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143521616 | chr5:104322269-104322270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376753686 | chr5:104322302-104322303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542820239 | chr5:104322303-104322304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113874602 | chr5:104322329-104322330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553651576 | chr5:104322332-104322333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573155815 | chr5:104322336-104322337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545012585 | chr5:104322342-104322343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572654183 | chr5:104322346-104322347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2964705 | chr5:104322379-104322380 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs183359764 | chr5:104322418-104322419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544726020 | chr5:104322431-104322432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10477841 | chr5:104322481-104322482 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs186544719 | chr5:104322529-104322530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145903254 | chr5:104322548-104322549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565987996 | chr5:104322558-104322559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528438613 | chr5:104322563-104322564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112040542 | chr5:104322588-104322589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs138358621 | chr5:104322596-104322597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533087157 | chr5:104322600-104322601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149245374 | chr5:104322607-104322608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567592434 | chr5:104322627-104322628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536626770 | chr5:104322647-104322648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551606476 | chr5:104322650-104322651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Obesity | 20622171 | CNVD |
Schizophrenia | 21346763 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:104321200-104321400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr5:104322000-104322200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr5:104322000-104323400 | Enhancers | Fetal Intestine Small | intestine |
4 | chr5:104322000-104323600 | Enhancers | Fetal Intestine Large | intestine |
5 | chr5:104322600-104324600 | Enhancers | K562 | blood |
6 | chr5:104324800-104326000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr5:104325200-104326400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |